These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 22818272

  • 1. Cerebroventricular clozapine would be a viable treatment modality for clozapine-dependent schizophrenia patients with neutropenia.
    Alisky JM.
    Med Hypotheses; 2012 Oct; 79(4):497-9. PubMed ID: 22818272
    [Abstract] [Full Text] [Related]

  • 2. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
    Myles N, Myles H, Clark SR, Bird R, Siskind D.
    Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
    [Abstract] [Full Text] [Related]

  • 3. Blood dyscrasias in clozapine-treated patients in Italy.
    Lambertenghi Deliliers G.
    Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
    [Abstract] [Full Text] [Related]

  • 4. Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide.
    Silva E, Higgins M, Hammer B, Stephenson P.
    BMC Psychiatry; 2020 Jun 05; 20(1):279. PubMed ID: 32503471
    [Abstract] [Full Text] [Related]

  • 5. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E, Taylor D.
    CNS Drugs; 2007 Jun 05; 21(1):25-35. PubMed ID: 17190527
    [Abstract] [Full Text] [Related]

  • 6. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
    Lertxundi U, Sanchez P, Hernandez R, Elizagarate E.
    J Clin Psychiatry; 2011 Dec 05; 72(12):1659. PubMed ID: 22244024
    [No Abstract] [Full Text] [Related]

  • 7. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N, Gee S, Whiskey E, Taylor D, Mijovic A, Gaughran F, Shergill S, MacCabe JH.
    J Clin Psychiatry; 2015 Nov 05; 76(11):e1410-6. PubMed ID: 26646037
    [Abstract] [Full Text] [Related]

  • 8. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S, Rosenius S, Spigset O.
    Int Clin Psychopharmacol; 2003 May 05; 18(3):173-4. PubMed ID: 12702898
    [Abstract] [Full Text] [Related]

  • 9. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L, Cazard F.
    Encephale; 2016 Aug 05; 42(4):346-53. PubMed ID: 27109327
    [Abstract] [Full Text] [Related]

  • 10. Clozapine re-challenge under the cover of Filgrastim.
    Gopalakrishnan R, Subhalakshmi TP, Kuruvilla A, Jacob KS.
    J Postgrad Med; 2013 Aug 05; 59(1):54-5. PubMed ID: 23525060
    [Abstract] [Full Text] [Related]

  • 11. Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia.
    Mathewson KA, Lindenmayer JP.
    J Clin Psychopharmacol; 2007 Dec 05; 27(6):714-5. PubMed ID: 18004146
    [No Abstract] [Full Text] [Related]

  • 12. Continuing clozapine despite recurrent neutropenia: A 8 year follow-up case report with granulocyte-colony stimulating factor as-required use.
    Demers MF, Fortier L, Corbeil O, Breault AS, Roy MA.
    Asian J Psychiatr; 2020 Feb 05; 48():101541. PubMed ID: 30314715
    [No Abstract] [Full Text] [Related]

  • 13. Reason for clozapine cessation.
    Pai NB, Vella SC.
    Acta Psychiatr Scand; 2012 Jan 05; 125(1):39-44. PubMed ID: 22017729
    [Abstract] [Full Text] [Related]

  • 14. [Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs].
    Sénéchal A, Landry P, Deschamps R, Lessard M.
    Encephale; 2002 Jan 05; 28(6 Pt 1):567-9. PubMed ID: 12506270
    [Abstract] [Full Text] [Related]

  • 15. Clozapine: balancing safety with superior antipsychotic efficacy.
    Meltzer HY.
    Clin Schizophr Relat Psychoses; 2012 Oct 05; 6(3):134-44. PubMed ID: 23006238
    [Abstract] [Full Text] [Related]

  • 16. Controls on clozapine must be reviewed.
    Drew LR.
    Aust N Z J Psychiatry; 2010 May 05; 44(5):490. PubMed ID: 20397797
    [No Abstract] [Full Text] [Related]

  • 17. Clozapine, agranulocytosis, and benign ethnic neutropenia.
    Rajagopal S.
    Postgrad Med J; 2005 Sep 05; 81(959):545-6. PubMed ID: 16143678
    [No Abstract] [Full Text] [Related]

  • 18. Management of treatment resistant schizophrenia unresponsive to clozapine.
    Barnes TR, McEvedy CJ, Nelson HE.
    Br J Psychiatry Suppl; 1996 Dec 05; (31):31-40. PubMed ID: 8968653
    [No Abstract] [Full Text] [Related]

  • 19. Clozapine-induced agranulocytosis.
    Fenner S, Date R.
    Aust N Z J Psychiatry; 1996 Dec 05; 30(6):874-5. PubMed ID: 9034483
    [No Abstract] [Full Text] [Related]

  • 20. The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital.
    Maskasame S, Krisanaprakornkit T, Khiewyoo J.
    J Med Assoc Thai; 2007 Oct 05; 90(10):2175-80. PubMed ID: 18041439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.